Sherry A. Bradford State University at Buffalo New York Tel: 7168607800
Dr. Bradford has a PhD in Medical Biochemistry-Oncology from the Roswell Park Cancer Institute, Division of SUNY at Buffalo School of Medical and Biomedical Sciences (on a full scholarship). She is the founder of AccuTheranostics and the inventor of the various patents. Founded the PROI Foundation to assist cancer patients; Co-Founder of S.S. Formulations (Skin Products). She was awarded the Award for Excellence in Research from the American Federation for Clinical Research, Business First – Women of Influence-Innovation Award, Business First – Who’s Who in Healthcare, Erie Community College Distinguished Alumni Award, [email protected] Buffalo Award for Excellence in Research Award – 1st Place, American Federation of Clinical Research Award – First Place, NYC and Award Roswell Park Cancer Institute Research Forum. She has authored many scientific papers and book chapters; and currently sits on two editorial boards; and been an invited speaker at many national and international meetings She is a member of many major professional cancer organizations including, ASCO, AACR and AAAS and a “grass-roots” member of the International Metabolic Cancer Group. As Chief Scientific Officer, she guides the day-to-day research directives as well as the clinical laboratory operations. She specializes in the field of cancer research and treatment, determined to make a meaningful difference in the lives of those faced with the disease. Her overall vision is to develop a state-of-the-art clinical laboratory to empower patients in determining and deciding their course of therapy eventuating into a positive outcome concurrent with quality-of-life; demonstrated through her initiatives of research individualized personal medicine assessment technologies that translate into the clinical setting.
Chemotherapy, Ovarian cancer